Pentamidine Isethionate (DBL) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: pentamidine
Pack: Pentamidine Isethionate (DBL) 300 mg powder for injection, 1 vial
Brand name
(ARTG)
: DBL PENTAMIDINE ISETHIONATE 300mg powder for injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Pentamidine isethionate is indicated for intravenous administration in the treatment of the following conditions: . As an alternative first line treatment for Pneumocystis carinii infection in AIDS patients; . As second line treatment for Pneumocystis carinii infection in non-AIDS patients; . As second line treatment of Leishmaniasis (visceral and cutaneous), except Leishmania Aethiopica where it may be used as first line treatment; . As second line treatment for Trypanosomiasis (except for the Trypanosomiasis Rhodesiense strain due to lack of efficacy).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Intravenous
- White to nearly white powder or plug.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1x300mg pack
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is
- 5x300mg(E) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient pentamidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
